BioVaxys Technology Corp.
BioVaxys Technology Corp. (BIOV.CN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIOV.CN · as of Jun 8, 2026
Key Statistics
Explore BioVaxys Technology Corp. Data
biov.cn stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
biov.cn competitorsBIOV.CN
APS.TO
AVNT.TO
AYUR.CN
BETR.CN
DMED.CNStock Performance
Full HistoryAbout BioVaxys Technology Corp.
BioVaxys Technology Corp. a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. It develops BVX-0320, a monovalent SARS-CoV-2 vaccine; and BVX-0918A, a haptenized tum…
what is biovaxys technology corp. · biov.cn stock overview · biovaxys technology corp. company profile · who is biovaxys technology corp. ceo · biov.cn CNQ · biovaxys technology corp. headquarters · biovaxys technology corp. business segments
About Stock Overview & Key Data
BioVaxys Technology Corp. (BIOV.CN) is a Healthcare company in the Biotechnology industry, listed on CNQ since Nov 27, 2018. As of the latest trading session, BIOV.CN stock price is $0.07, with a market capitalization of $2.0M. The stock has returned -82.50% over the past 12 months and -68.18% year-to-date.
In fiscal year 2024, BioVaxys Technology Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioVaxys Technology Corp. (BIOV.CN) stock price is $0.07. The stock is traded on CNQ under the ticker symbol BIOV.CN. The 52-week range is $0.03 – $0.40.